The Unique U.S.-Russian Relationship in Biological Science and Biotechnology Recent Experience and Future Directions (2013) / Chapter Skim
Currently Skimming:
4 Applications of Science in the Public and Private Sectors
4 Applications of Science in the Public and Private Sectors
Pages 61-72
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 61... ...
organizations are searching for opportunities to play a constructive role in the outreach activities of Russian research and service institutions. However, in all countries there are many failed attempts for the relatively few successes in introducing into public- and private-sector markets products and services based on development of advanced technology, and particularly biomedical products.
|
From page 62... ...
chain that are important for the commercialization of biomedical, agricultural, and other technologies. New institutional components include the mega-incubator to be located at Skolkovo near Moscow, together with supporting incubators in other cities throughout the country and abroad; the state-owned enterprise Rusnano, which has development of biomedical technologies on its list of priorities; and various venture capital funds in Russia, which are also targeting the biomedical sector.
|
From page 63... ...
At the same time, Russian, U.S., and other international companies have been producing and selling a few items based on biological science and biotechnology innovations within Russia. Of course, many international firms have been vying for sales to the Russian government and regional governments of imported goods and services, while local companies and local entrepreneurs have difficulties winning open and fair competitions at the national, regional, and municipal levels.
|
From page 64... ...
This activity helped his institute obtain recognition for Good Laboratory Practices and Good Manufacturing Practices, as a prelude for profitable production of several lines of drugs. Turning to outreach activities of well-established Russian research institutes, the Central Research Institute of Epidemiology in Moscow has developed kits for detecting and characterizing the presence of a variety of diseases, at times with support from U.S.
|
From page 65... ...
In 2008, DOS launched a limited pilot program to help jump-start small biotech enterprises in Russia. For years, the lack of a vibrant small and medium business sector has been one of the reasons that Russia has not moved in a discernible manner toward its goal of joining the ranks of countries that boast knowledge-based economies.
|
From page 66... ...
Unfortunately, however, some projects encountered administrative difficulties, and the program was terminated, at least temporarily. Even though Russia is not accustomed to supporting risky propositions, the approach may deserve reconsideration as a novel way to move products forward.
|
From page 67... ...
With DOE laboratories serving as brokers of initial contacts between interested Russian organizations and members of USIC, partnerships for bringing to market viable technology-based products have been formed with varying degrees of commercial success. Over the lifetime of the program there have been about 150 projects carried out in Russia, with about 30 percent linked to the biomedical sector (Box 4-6)
|
From page 68... ...
They have played constructive roles in upgrading Russian approaches for providing important services in the medical field.
|
From page 69... ...
This joint effort has sup ported presentation of Russian pharmaceutical products in compliance with international quality standards, thereby facilitating their routes to international markets. SOURCE: ISTC Annual Report 2011, p.
|
From page 70... ...
They have often demonstrated a level of mutual interest in developing stronger commercial ties. The governments are working together to encourage foreign investment in both directions by improving the legal and economic frameworks for foreign companies to conduct business in the respective countries.
|
From page 71... ...
(See Appendix E.4.) Summarizing, the two governments can provide incentives for individual scientists, research teams, and commercial organizations to explore and propose new topics for bilateral cooperation.
|
From page 72... ...
programs to link Russian research institutions with small U.S. biotechnology firms have been important, and particularly programs supported by DOE.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.